The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Antibody dependent cellular cytotoxicity activity of a novel anti-PD-L1 antibody, avelumab (MSB0010718C), on human tumor cells.
 
Kwong-Yok Tsang
No Relationships to Disclose
 
Benjamin Boyerinas
No Relationships to Disclose
 
Caroline Jochems
No Relationships to Disclose
 
Massimo Fantini
No Relationships to Disclose
 
Christopher Ryan Heery
No Relationships to Disclose
 
Ravi Amrit Madan
No Relationships to Disclose
 
James L. Gulley
Consulting or Advisory Role - Prime Oncology; TRM Oncology
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology
 
Jeffrey Schlom
Research Funding - Bavarian Nordic (Inst); EMD Serono (Inst); GlobeImmune (Inst)
Patents, Royalties, Other Intellectual Property - Bavarian Nordic (Inst); GlobeImmune (Inst)